Lemaitre Vascular (LMAT) Cash from Financing Activities (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Cash from Financing Activities data on file, last reported at -$3.2 million in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$3.2 million, up 38.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.5 million (down 108.19% YoY), and the FY2025 annual result was -$14.5 million, down 109.2% from the prior year.
• Cash from Financing Activities grew to -$3.2 million in Q1 2026 per LMAT's latest filing, from -$3.6 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $164.1 million in Q4 2024 and troughed at -$5.2 million in Q1 2025.
• A 5-year average of $7.3 million and a median of -$2.7 million in 2023 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities soared 6208.75% in 2024, then slumped 13533.33% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at -$2.1 million in 2022, then decreased by 26.58% to -$2.7 million in 2023, then soared by 6208.75% to $164.1 million in 2024, then sank by 102.19% to -$3.6 million in 2025, then grew by 10.26% to -$3.2 million in 2026.
• Business Quant data shows LMAT's Cash from Financing Activities at -$3.2 million in Q1 2026, -$3.6 million in Q4 2025, and -$2.9 million in Q3 2025.